Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew H Kaye

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2015
Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiformeIwan E Bennett, Hui Guo, Nicole Kountouri, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
American Journal of Ophthalmology|June 14, 2020
Prognostic Utility of Optical Coherence Tomography for Long-Term Visual Recovery Following Pituitary Tumor SurgeryMichael T M Wang, James King, R C Andrew Symons, et al.
Neuro-Oncology Advances|April 4, 2024
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in gliomaJordan J Jones, Hong Nguyen, Stephen Q Wong, et al.
Medical Oncology (Northwood, London, England)|April 22, 2016
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomibZammam Areeb, Stanley S Stylli, Thomas M B Ware, et al.
Scientific Reports|October 21, 2020
Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastomaZammam Areeb, Sarah F Stuart, Alice J West, et al.
Epilepsia|June 7, 2014
IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomasSimon V Liubinas, Giovanna M D'Abaco, Bradford M Moffat, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 4, 2023
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent mannerClarissa A Whitehead, Haoyun Fang, Huaqi Su, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 9, 2015
Tibial fracture exacerbates traumatic brain injury outcomes and neuroinflammation in a novel mouse model of multitraumaSandy R Shultz, Mujun Sun, David K Wright, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 27, 2015
Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiformeIwan E Bennett, Hui Guo, Nicole Kountouri, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Oncotarget|June 6, 2015
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cellsJared Ching, Stephanie Amiridis, Stanley S Stylli, et al.
American Journal of Ophthalmology|June 14, 2020
Prognostic Utility of Optical Coherence Tomography for Long-Term Visual Recovery Following Pituitary Tumor SurgeryMichael T M Wang, James King, R C Andrew Symons, et al.
Neuro-Oncology Advances|April 4, 2024
Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in gliomaJordan J Jones, Hong Nguyen, Stephen Q Wong, et al.
Medical Oncology (Northwood, London, England)|April 22, 2016
Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomibZammam Areeb, Stanley S Stylli, Thomas M B Ware, et al.
Scientific Reports|October 21, 2020
Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastomaZammam Areeb, Sarah F Stuart, Alice J West, et al.
Epilepsia|June 7, 2014
IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomasSimon V Liubinas, Giovanna M D'Abaco, Bradford M Moffat, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 4, 2023
Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent mannerClarissa A Whitehead, Haoyun Fang, Huaqi Su, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 9, 2015
Tibial fracture exacerbates traumatic brain injury outcomes and neuroinflammation in a novel mouse model of multitraumaSandy R Shultz, Mujun Sun, David K Wright, et al.
Pageof 16